The act continues the prescription drug monitoring program (program) indefinitely.Additionally, the act:Authorizes the state board of pharmacy (board) to promulgate rules that identify a list of prescription drugs that are not currently listed as controlled substances and require such drugs to be tracked through the program;
Authorizes each coroner to authorize deputy coroners to access the program;
Authorizes the board to create a data retention schedule for information obtained and stored by the program;
Eliminates the requirements that the board seek gifts, grants, and donations in order to maintain the program and report annually to committees of reference of the general assembly on the gifts, grants, and donations; and
Makes a technical change to remove a reference to the department of health care policy and financing from the statute as that department does not have access to the program.(Note: This summary applies to this bill as enacted.)

Read More

Statutes affected:
Introduced (02/17/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Engrossed (04/27/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Reengrossed (04/28/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Revised (05/25/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Rerevised (05/28/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Final Act (06/11/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104
Signed Act (06/22/2021): 12-280-403, 12-280-404, 12-280-405, 24-34-104